Tahereh Rostami
Overview
Explore the profile of Tahereh Rostami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
97
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kiumarsi A, Alaei A, Nikbakht M, Mohammadi S, Ostad-Ali M, Rasti Z, et al.
Front Immunol
. 2025 Jan;
15():1475448.
PMID: 39845947
Background: With recent advances in clinical practice, including the use of reduced-toxicity conditioning regimens and innovative approaches such as ex vivo TCRαβ/CD19 depletion of haploidentical donor stem cells or post-transplant...
2.
Mahmoudi P, Kaveh-Ahangaran R, Rostami T, Hosseini A, Vaezi M, Shahrami B
J Med Case Rep
. 2024 Nov;
18(1):544.
PMID: 39529083
Background: Allogeneic hematopoietic stem cell transplantation is a definitive cure for eligible patients with thalassemia major, and calcineurin inhibitors are essential for preventing graft-versus-host disease. Although invaluable, there are few...
3.
Tajik S, Fazlollahi M, Alizadeh Z, Badalzadeh M, Houshmand M, Razaghian A, et al.
Pediatr Allergy Immunol
. 2024 Nov;
35(11):e14264.
PMID: 39485047
Background: Primary immunodeficiency diseases (inborn errors of immunity) with partial albinism are a group of autosomal recessive syndromes including Chediak Higashi Syndrome (CHS), Griscelli Syndrome type 2 (GS2), Hermansky-Pudlak Syndromes...
4.
Alemi H, Khavandgar N, Oskouie I, Mardani-Fard H, Rostami T, AleTaha A, et al.
Medicine (Baltimore)
. 2024 Jun;
103(26):e38511.
PMID: 38941389
Over the past 3 decades numerous studies have reported an association between systemic lupus erythematosus (SLE) and thyroid cancers. However, there has been no scientometric analysis in this area of...
5.
Rostami T, Rad S, Rostami M, Mirhosseini S, Alemi H, Khavandgar N, et al.
Cell Transplant
. 2024 Apr;
33:9636897241246351.
PMID: 38680015
While exagamglogene autotemcel (Casgevy) and lovotibeglogene autotemcel (Lyfgenia) have been approved by the US Food and Drug Administration (FDA) as the first cell-based gene therapies for the treatment of patients...
6.
Rostami T, Rostami M, Mirhosseini A, Mohammadi S, Nikbakht M, Alemi H, et al.
Stem Cell Res Ther
. 2024 Apr;
15(1):111.
PMID: 38644499
Background: Graft failure (GF) is a rare but serious complication after allogeneic hematopoietic stem cell transplantation (HSCT). Prevention of graft failure remains the most advisable approach as there is no...
7.
Bakhtiari T, Ahmadvand M, Yaghmaie M, Sadeghi A, Mousavi S, Rostami T, et al.
BMC Immunol
. 2023 Jun;
24(1):10.
PMID: 37340345
Background: KIR/HLA mismatch in hematopoietic stem cell transplantation (HSCT), particularly in patients with acute myeloid leukemia (AML), was related to decreased recurrence rates, improved engraftment, and a reduction in graft-versus-host...
8.
Nekoeian S, Rostami T, Norouzy A, Hussein S, Tavoosidana G, Chahardouli B, et al.
Oncol Res
. 2023 Jun;
30(6):259-268.
PMID: 37303492
Acute lymphoblastic leukemia (ALL) is a malignancy of bone marrow lymphoid precursors. Despite effective treatments, the causes of its progression or recurrence are still unknown. Finding prognostic biomarkers is needed...
9.
Bakhtiari T, Ahmadvand M, Salmaninejad A, Ghaderi A, Yaghmaie M, Sadeghi A, et al.
Curr Cancer Drug Targets
. 2023 May;
23(11):868-878.
PMID: 37226789
Natural killer (NK) cell behavior and function are controlled by a balance between negative or positive signals generated by an extensive array of activating and inhibiting receptors, including killer cell...
10.
Ansari F, Behfar M, Naji P, Darvish Z, Rostami T, Mohseni R, et al.
Health Sci Rep
. 2023 Apr;
6(4):e1180.
PMID: 37033392
Objectives: Fanconi anemia (FA) is a rare, heterogeneous, inherited disorder. Allogeneic hematopoietic stem cell transplantation (HSCT) represents the only therapeutic option to restore normal hematopoiesis. This study reports the outcomes...